Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 90.00
Bid: 88.00
Ask: 92.00
Change: 2.00 (2.27%)
Spread: 4.00 (4.545%)
Open: 88.00
High: 91.50
Low: 88.00
Prev. Close: 88.00
CNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

7 Sep 2021 07:00

RNS Number : 9051K
Concurrent Technologies PLC
07 September 2021
 

7 September 2021

Concurrent Technologies Plc

(the "Company" or the "Group")

 

Interim Results for the six months ended 30 June 2021

 

Concurrent Technologies Plc (AIM: CNC), a world leading specialist in the design and manufacture of high-end embedded computer boards for critical applications, announces interim results for the six months to 30 June 2021, reflecting a positive trading period with strong sales, profit before tax and investment.

 

Financial Highlights

· Revenue of £9.3m (H1 2020: £9.2m)

· Gross profit of £5.1m (H1 2020: £4.9m)

· Gross margin of 54.3% (H1 2020: 52.9%)

· Group operating profit of £1.6m (H1 2020: £1.2m)

· Profit before tax of £1.5m (H1 2020: £1.2m)

· EPS of 2.09 pence (H1 2020: 1.62 pence)

· Interim dividend increased to 1.15p per share (H1 2020: 1.10p)

· Cash balance (including cash deposits) at 30 June 2021 of £12.4m (H1 2020: £10.0m)

 

Operational Highlights

 

· Largest market sector is defence at 71% of revenue

· Record order book achieved during the period of £15.9m (H1 2020: £13.9m)

· Global customer base remains solid with exports generating 91% of revenue (H1 2020: 96%)

· R&D cost during the period was £1.6m (H1 2020: £1.8m)

· Component shortages being managed, although challenges remain across the global supply chain

 

Mark Cubitt, Chairman of Concurrent Technologies Plc, commented: "Even in the face of unprecedented worldwide supply chain disruption, the first half performance has been robust with sales at 2020 levels, improved margins, a strengthened balance sheet, and a record order book ensuring the pipeline of future profitability. There remains uncertainty on the timing of some shipments in Q4 2021 and into 2022, driven by component availability, which may slip revenues into 2022 but there is no evidence yet of cancellations from customers. The Board believe the changes in management structure and leadership team will leave the Company well placed to leverage its reputation in the market for future growth and improved profitability."

 

Enquiries:

Concurrent Technologies Plc Dr Miles Adcock, Chief Executive

Jonathan Martin, CFO

 

+44 (0)1206 752626

 

 

SEC Newgate (Financial PR) Bob Huxford

Isabelle Smurfit

 

+44 (0)20 7653 9848+44 (0)20 3757 3411

 

 

Cenkos Securities Plc (NOMAD) Neil McDonald

Peter Lynch

+44 (0)131 220 9771

+44 (0)131 220 9772

 

 

About Concurrent Technologies Plc

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high-performance, long-life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest 11th generation embedded Intel® Core™, Intel® Xeon® and Intel Atom® processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded Operating Systems. The products are sold world-wide.

 

For more information on Concurrent Technologies Plc and its products please visit www.gocct.com.

 

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

 

CHAIRMAN'S STATEMENT

I am pleased to announce the trading performance has continued on from the strong results reported for 2020, with solid sales in the first half of 2021 and a growing order book, despite the challenging worldwide supply chain disruption.

The end of the first half also saw the beginning of the smooth transition from Jane Annear to Miles Adcock as CEO. Jane has been extremely helpful and supportive during this period which typifies the commitment, professionalism and drive, that she demonstrated throughout her career with Concurrent and which has brought the Company to its current strong position.

It is with great sadness that I learnt Clive Mannering-Thomson had passed away in August after a brief illness. Clive was a long serving member of the Concurrent Board and true gentleman and our thoughts are with his family and friends at this difficult time.

CHIEF EXECUTIVE'S REVIEW

 

Financial Summary

 

The Company continued to trade and operate in a largely normal fashion during the first half of 2021 with production, sales and development maintained at typical operational levels. Revenue for the period was similar at £9.3m (H1 2020: £9.2m) while gross margin increased to 54.3% (H1 2020: 52.9%). Consequently, gross profit increased to £5.1m (H1 2020: £4.9m). The unaudited profit before tax (PBT) for the period was £1.6m (H1 2020: £1.2m). The associated earnings per share (EPS) were 2.09 p (H1 2020: 1.62p).

The balance sheet remains very strong, with no debt and cash balances (including cash deposits) at 30 June 2021 of £12.4m (H1 2020: £10.0m).

Dividend

 

Given the strong cash position and the robust balance sheet, the Board has declared an interim dividend of 1.15p per share (H1 2020: 1.10p) - an increase of 4.5%. The total cost of this dividend will amount to £843,680. The ex-dividend date for this interim dividend is 16 September 2021, the record date is 17 September 2021 and the payment date is 1 October 2021.

Review of Operations

 

As an essential defence supplier, production at the Company's Colchester headquarters continued uninterrupted during each lockdown period and the Company has not applied for support under any Government COVID-19 initiatives. Our preparations for Brexit led to minimal impact on the business and no impact on sales to our customers.

The unprecedented worldwide supply chain shortages are a major risk to all companies and Concurrent is no exception. During 2021 we have so far managed the disruption and protected the supply of goods to our customers, but the situation is deteriorating and is expected to last well into 2022. This may lead to some revenue slipping from 2021 to 2022 but to date we have seen no evidence of program or platform cancellations from our customers. Rather, we have seen growing support from our customer base, leading to a record order book of £15.9m at the period end.

Sales within the defence market increased to £6.6m (H1 2020: £6.3m) representing 71% (H1 2020: 68%) of revenue and exports were 91% (H1 2020: 96%). While defence is still our primary target market, we do see myriad opportunities in the telecoms and other sectors which are being pursued with vigour.

During 2021 we have also seen the final closure of the Concurrent office in India as planned and the subsequent expansion and re-alignment of engineering capabilities in the UK. This has resulted in an overall decrease in R&D spend in H1 2021 to £1.6m (H1 2020: £1.8m) as expected, and this reduction has not had a detrimental impact on output from the function.

 

Through extensive co-operation, development and testing work Intel have elevated us to Titanium partner status thus strengthening our ties with our leading technology supplier. Launches and deployment of the new 3U CompactPCI and AMC boards has continued, along with the development of our software products.

 

Future Plans

 

The current leadership team is being revitalised with the introduction of an HR Director and a Quality & Business Improvement Director. Recruitment for these positions will be completed during the second half of the year. Along with these new appointments there will be some changes in the internal reporting structure which will allow the organisation to increase its capacity to manage new projects and develop the business.

The new team will revise the medium and long-term strategic plan focusing on product lead times and revenue growth.

 

Outlook

 

Even in the face of unprecedented worldwide supply chain disruption, the first half performance has been robust with sales at 2020 levels, improved margins, a strengthened balance sheet and a record order book ensuring the pipeline of future profitability. The Board believe the changes in management structure and leadership team will leave the Company well placed to leverage its reputation in the market for future growth and improved profitability.

 

Dr Miles Adcock

CEO

7 September 2021

 

All companies and product names are trademarks of their respective organisations.

CONDENSED CONSOLIDATED STATEMENT OF

COMPREHENSIVE INCOME

Unaudited interim results to 30 June 2021

 

Note

Six months ended

30/06/21

Six months ended

30/06/20

Year ended 31/12/20

£

£

£

CONTINUING OPERATIONS

Revenue

9,315,839

9,191,045

21,141,294

Cost of sales

4,255,669

4,325,867

9,780,750

Gross profit

5,060,170

4,865,178

11,360,544

Net operating expenses

3,439,699

3,627,665

8,444,962

Group operating profit

1,620,471

1,237,513

2,915,582

Finance costs

(32,233)

(40,035)

(83,985)

Finance income

3,696

23,171

16,480

Profit before tax

1,591,934

1,220,649

2,848,077

Tax

56,559

25,858

98,167

Profit for the period

1,535,375

1,194,791

2,749,910

Other Comprehensive Income

Exchange differences on translating foreign operations

(19,626)

419,634

(283,681)

Tax relating to components of other comprehensive income

-

-

-

Other Comprehensive Income for the period, net of tax

(19,626)

419,634

(283,681)

Total Comprehensive Income for the period

1,515,749

1,614,425

2,466,229

Profit for the period attributable to:

Equity holders of the parent

1,535,375

1,194,791

2,749,910

Total Comprehensive Income attributable to:

Equity holders of the parent

1,515,749

1,614,425

2,466,229

Earnings per share

Basic earnings per share

4

2.09p

1.62p

3.75p

Diluted earnings per share

4

2.09p

1.62p

3.74p

 

CONDENSED CONSOLIDATED BALANCE SHEET

Unaudited interim results to 30 June 2021

 

As at

As at

As at

30/06/21

30/06/20

31/12/20

ASSETS

£

£

£

Non-current assets

Property, plant and equipment

1,735,125

1,683,186

1,734,965

Intangible assets

7,333,105

7,917,503

7,205,581

Deferred tax assets

88,455

100,930

134,775

9,156,685

9,701,619

9,075,321

Current assets

Inventories

6,619,081

6,546,821

5,533,574

Trade and other receivables

2,614,711

3,132,765

2,356,157

Current tax assets

351,104

334,082

305,113

Cash and cash equivalents

12,386,445

10,034,786

11,765,974

21,971,341

20,048,454

19,960,818

Total assets

31,128,026

29,750,073

29,036,139

LIABILITIES

Non-current liabilities

Deferred tax liabilities

1,638,947

1,537,532

1,571,830

Trade and other payables

518,919

529,953

704,800

Long term provisions

18,256

14,964

16,162

2,176,122

1,552,496

2,292,792

Current liabilities

Trade and other payables

5,913,855

5,410,722

4,143,522

Short term provisions

18,256

15,382

16,354

Current tax liabilities

33,190

-

26,504

5,965,301

5,426,104

4,186,380

Total liabilities

8,141,423

6,978,600

6,479,172

Net assets

22,986,603

22,771,473

22,556,967

EQUITY

Capital and reserves

Share capital

739,000

739,000

739,000

Share premium account

3,699,105

3,699,105

3,699,105

Capital redemption reserve

256,976

256,976

256,976

Cumulative translation reserve

(140,919)

582,022

(121,293)

Profit and loss account

18,432,441

17,494,370

17,983,179

Equity attributable to equity holders of the parent

22,986,603

22,771,473

22,556,967

Total equity

22,986,603

22,771,473

22,556,967

CONDENSED CONSOLIDATED CASH FLOW STATEMENT

Unaudited interim results to 30 June 2021

 

Six months ended

30/06/21

Six months ended

30/06/20

Year ended 31/12/20

£

£

£

Cash flows from operating activities

Profit before tax for the period

1,591,934

1,220,649

2,848,077

Adjustments for:

Finance income

(3,696)

(23,171)

(16,480)

Finance costs

32,233

40,035

83,985

Depreciation

84,757

142,154

282,563

Amortisation

606,453

888,299

1,793,628

Impairment loss

150,000

125,000

888,579

Loss on disposal of property, plant and equipment

28,778

-

-

Share-based payment

16,339

-

6,991

Exchange differences

(16,762)

467,772

(300,568)

(Increase)/decrease in inventories

(1,085,507)

(1,448,914)

(435,667)

(Increase)/decrease in trade and other receivables

(258,554)

(428,805)

347,803

Increase/(decrease) in trade and other payables

1,645,319

493,329

(9,354)

Cash generated from operations

2,791,294

1,476,348

5,489,557

Tax received/(paid)

(21,110)

(1,209)

40,535

Net cash generated from operating activities

2,770,184

1,475,139

5,530,092

Cash flows from investing activities

Interest received

3,696

23,171

16,480

Cash released from/(placed on) deposit

-

-

-

Purchases of property, plant and equipment

(115,045)

(182,469)

(385,964)

Proceeds from sale of property, plant and equipment

-

-

-

Purchases of intangible assets

(883,983)

(939,585)

(1,896,659)

Net cash used in investing activities

(995,332)

(1,098,883)

(2,266,143)

Cash flows from financing activities

Equity dividends paid

(1,063,769)

(1,054,561)

(1,864,968)

Repayment of leasing liabilities

(56,871)

(50,648)

(108,195)

Interest paid

(32,233)

(40,035)

(83,985)

Sale of treasury shares

-

368,550

47,529

Net cash used in financing activities

(1,152,873)

(776,694)

(2,009,619)

Effects of exchange rate changes on cash and cash equivalents

(1,508)

(52,678)

23,742

Net increase/(decrease) in cash

620,471

(453,116)

1,278,072

Cash at beginning of period

11,765,974

10,487,902

10,487,902

Cash at the end of the period

12,386,445

10,034,786

11,765,974

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

Unaudited interim results to 30 June 2021

 

Share

capital

Share

Premium

Capital

redemption

reserve

Cumulative

translation

reserve

Profit

and loss

account

Total

equity

£

£

£

£

£

£

Balance at 1 January 2020

739,000

3,699,105

256,976

162,388

17,027,245

21,884,714

Profit for the period

-

-

-

-

1,194,791

1,194,791

Exchange differences on translating foreign operations

-

-

-

419,634

-

419,634

Total recognised comprehensive income for the period

-

-

-

419,634

1,194,791

1,614,425

Share-based payment

-

-

-

-

-

-

Deferred tax on share-based payment

-

-

-

-

(41,655)

(41,655)

Dividends paid

-

-

-

-

(1,054,561)

(1,054,561)

Sale of treasury shares

-

-

-

-

368,550

368,550

Balance at 30 June 2020

739,000

3,699,105

256,976

582,022

17,494,370

22,771,473

Profit for the period

-

-

-

-

1,555,119

1,555,119

Exchange differences on translating foreign operations

-

-

-

(703,315)

-

(703,315)

Total recognised comprehensive income for the period

-

-

-

(703,315)

1,555,119

851,804

Share-based payment

-

-

-

-

6,991

6,991

Deferred tax on share-based payment

-

-

-

-

58,127

58,127

Dividends paid

-

-

-

-

(810,407)

(810,407)

Sale of treasury shares

-

-

-

-

(321,021)

(321,021)

Balance at 31 December 2020

739,000

3,699,105

256,976

(121,293)

17,983,179

22,556,967

Profit for the period

-

-

-

-

1,535,375

1,535,375

Exchange differences on translating foreign operations

-

-

-

(19,626)

-

(19,626)

Total recognised comprehensive income for the period

-

-

-

(19,626)

1,535,375

1,515,749

Share-based payment

-

-

-

-

16,339

16,339

Deferred tax on share-based payment

-

-

-

-

(38,683)

(38,683)

Dividends paid

-

-

-

-

(1,063,769)

(1,063,769)

Sale of treasury shares

-

-

-

-

-

-

Balance at 30 June 2021

739,000

3,699,105

256,976

(140,919)

18,432,441

22,986,603

 

 

NOTES TO THE INTERIM REPORT

 

1.

General information

 

The principal activity of the Group is design, manufacture and supply of innovative high-end embedded single board computers and complementary accessories aimed at a wide base of customers within the defence, telecommunications, aerospace, transport, scientific and industrial markets.

 

Concurrent Technologies Plc ("the Company") is the Group's ultimate parent company. It is incorporated and domiciled in Great Britain. Concurrent Technologies Plc shares are listed on the Alternative Investment Market of the London Stock Exchange.

 

The Group's condensed consolidated interim financial statements are presented in pounds sterling (£), which is also the functional currency of the parent company.

 

These condensed consolidated interim financial statements, which are unaudited, have been approved for issue by the Board of Directors on 6 September, 2021.

 

The information relating to the six months ended 30 June 2020 and 30 June 2020 is unaudited and does not constitute statutory accounts within the meaning of section 434 of the Companies Act 2006. The statutory accounts for the year ended 31 December 2020, prepared in accordance with IFRSs (International Financial Reporting Standards) as adopted by the European Union, have been reported on by the Group's auditors and delivered to the Registrar of Companies. The auditors' report was unqualified, did not draw attention to any matters by way of emphasis and did not contain a statement under section 498 (2) or (3) of the Companies Act 2006.

 

2.

Summary of significant accounting policies

 

2.1

Basis of preparation

 

These condensed consolidated interim financial statements are for the six months ended 30 June 2021. They have been prepared in accordance with IAS 34 "Interim Financial Reporting". They do not include all of the information required for full annual financial statements, and should be read in conjunction with the consolidated financial statements of the Group for the year ended 31 December 2020, which have been prepared in accordance with adopted IFRSs.

 

The accounting policies applied and methods of computation are consistent with those of the annual financial statements for the year ended 31 December 2020, as described in those financial statements. The accounting policies have been consistently applied to all the periods presented.

 

There are no new IFRSs or IFRIC interpretations that are effective for the first time for the financial period beginning on or after 1 January 2021 that would be expected to have a material impact on the results or financial position of the Group.

 

 

2.2

Going Concern

 

The Directors are satisfied that the Group has sufficient resources to continue in operation for the foreseeable future, a period of not less than 12 months from the date of this report. Accordingly, they continue to adopt the going concern basis in preparing these condensed financial statements.

 

2.3

Taxation

 

Current tax expense is recognised in these condensed consolidated interim financial statements based on estimated effective tax rates for the full year.

 

3.

Segmental reporting

 

The Directors consider that the Group is engaged in a single segment of business, being design, manufacture and supply of high-end embedded computer products, and that therefore the Company has only a single operating segment. The key measure of performance used by the Board to assess the Group's performance is the Group's profit before tax, as calculated under IFRS, and therefore no reconciliation is required between the measure of profit or loss used by the Board and that contained in the condensed consolidated interim financial statements.

 

4.

Earnings per share

 

Basic earnings per share is calculated by dividing the profit attributable to ordinary equity holders for the period by the weighted average number of ordinary shares outstanding during the period.

 

Diluted earnings per share is calculated adjusting the weighted average number of ordinary shares outstanding to assume conversion of all contracted dilutive potential ordinary shares. The Company only has one category of dilutive potential ordinary shares, namely share options.

 

The inputs to the earnings per share calculation are shown below:

 

 

 

Six months ended

30/06/21

Six months ended

30/06/20

Year ended 31/12/20

£

£

£

Profit attributable to ordinary equity holders

1,535,375

1,194,791

2,749,910

Six months ended

30/06/21

Six months ended

30/06/20

Year ended 31/12/20

No

No

No

Weighted average number of ordinary

shares for basic earnings per share

73,363,490

73,673,490

72,523,722

Adjustment for share options

-

195,579

311,651

Weighted average number of ordinary shares for diluted earnings per share

73,363,490

73,869,069

73,565,372

 

 

7.

Shareholder Communication

A copy of these condensed interim financial statements is available from the Company's Registered Office at 4 Gilberd Court, Newcomen Way, Colchester, Essex, CO4 9WN, UK and from the Company's website at www.gocct.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR UNUWRAUUKRAR
Date   Source Headline
9th Apr 20247:00 amRNSNew Product Announcement
5th Feb 20247:00 amRNSBoard Appointment
17th Jan 20247:00 amRNSTrading update
21st Dec 20237:00 amRNSKey VME Contract Win
19th Dec 20231:07 pmRNSHolding(s) in Company
27th Nov 20237:00 amRNSTrading Update
9th Nov 20237:00 amRNSNew Product Announcement
8th Nov 20237:00 amRNSChange of Nominated Adviser
7th Nov 20237:00 amRNSAppointment of New Auditors
2nd Nov 20237:00 amRNSHolding(s) in Company
24th Oct 20237:00 amRNSDirector/PDMR Dealing - Issue of Share Options
28th Sep 20237:00 amRNSNew Product Announcement
19th Sep 20237:00 amRNSInterim Results
6th Sep 20237:00 amRNSAcquisition of Phillips Aerospace
5th Sep 202312:04 pmRNSHolding(s) in Company
5th Sep 20237:00 amRNSNotice of Results
4th Sep 20231:20 pmRNSResult of General Meeting
25th Aug 20237:00 amRNSResult of Retail Offer
24th Aug 20233:07 pmRNSResult of AGM
16th Aug 20237:05 amRNSRetail Offer for up to £0.3 million
16th Aug 20237:00 amRNSProposed Acquisition and Notice of General Meeting
11th Aug 20233:15 pmRNSHolding(s) in Company
8th Aug 20237:00 amRNSNew Product Announcement
1st Aug 202310:58 amRNSNew Product Announcement
20th Jul 20237:00 amRNSNotification of Major Holdings
18th Jul 20237:00 amRNSPosting of Annual Report and Notice of AGM
17th Jul 20237:00 amRNSPost-Close Trading Update
30th Jun 20237:00 amRNSResults for the year ended 31 December 2022
19th Jun 20237:00 amRNSUpdate on Audited Annual Results
12th Jun 20237:00 amRNSSignificant Systems Win
9th Jun 20235:11 pmRNSNotification of Major Holdings
7th Jun 20237:00 amRNSNew Distributor Agreement
5th Jun 20237:00 amRNSNotice of Results
24th Mar 20237:00 amRNSNew Product Announcement
21st Mar 20237:00 amRNSReseller Agreement
4th Jan 20237:00 amRNSPost-Close Trading Update
14th Dec 20227:00 amRNSPartnership Agreement
28th Oct 20227:00 amRNSIssue of Share options and PDMR dealing
5th Oct 20227:00 amRNSConcurrent Technologies Enters the Systems Market
26th Sep 20227:00 amRNSInterim Results
12th Sep 20227:00 amRNSNotice of Interim Results
24th Aug 202210:29 amRNSHolding(s) in Company
24th Aug 202210:27 amRNSHolding(s) in Company
19th Aug 202212:06 pmRNSHolding(s) in Company
13th Jul 20227:00 amRNSSupply Agreement
29th Jun 202212:55 pmRNSResult of AGM
30th May 20227:00 amRNSPosting of Annual Report & Notice of AGM
23rd May 20222:46 pmRNSIssue of Share options and PDMR dealing
12th May 20227:00 amRNSResults for the year ended 31 December 2021
11th May 20227:00 amRNSInvestor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.